BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19019431)

  • 21. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
    Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
    J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas.
    Haydeé Cottliar AS; Noriega MF; Narbaitz M; Rodríguez A; Slavutsky IR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):1-8. PubMed ID: 17074584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.
    Spence JM; Abumoussa A; Spence JP; Burack WR
    J Immunol; 2014 Nov; 193(10):4888-94. PubMed ID: 25311808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
    Capello D; Martini M; Gloghini A; Cerri M; Rasi S; Deambrogi C; Rossi D; Spina M; Tirelli U; Larocca LM; Carbone A; Gaidano G
    Haematologica; 2008 Aug; 93(8):1178-85. PubMed ID: 18556404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas.
    Malumbres R; Davis J; Ruiz P; Lossos IS
    Br J Haematol; 2007 Sep; 138(6):749-55. PubMed ID: 17760806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hypermethylation of DAP-kinase CpG island in the development of thyroid lymphoma.
    Nakatsuka S; Takakuwa T; Tomita Y; Miwa H; Matsuzuka F; Aozasa K
    Lab Invest; 2000 Nov; 80(11):1651-5. PubMed ID: 11092525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
    Montesinos-Rongen M; Van Roost D; Schaller C; Wiestler OD; Deckert M
    Blood; 2004 Mar; 103(5):1869-75. PubMed ID: 14592832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland.
    Kato I; Tajima K; Suchi T; Aozasa K; Matsuzuka F; Kuma K; Tominaga S
    Jpn J Cancer Res; 1985 Nov; 76(11):1085-90. PubMed ID: 3936828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic hypermutation signature in B-cell low-grade lymphomas.
    Tracey L; Aggarwal M; García-Cosio M; Villuendas R; Algara P; Sánchez-Beato M; Sánchez-Aguilera A; García JF; Rodríguez A; Camacho FI; Martínez N; Ruiz-Ballesteros E; Mollejo M; Piris MA
    Haematologica; 2008 Aug; 93(8):1186-94. PubMed ID: 18556400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
    Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B
    Blood; 2006 Aug; 108(3):1013-20. PubMed ID: 16614247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary thyroid lymphoma: case series with literature review.
    Kebapcilar L; Alacacioglu I; Comlekci A; Ozcan MA; Piskin O; Kargi A; Undar B; Yesil S
    J BUON; 2009; 14(2):295-9. PubMed ID: 19650181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).
    Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Am J Clin Pathol; 2009 Mar; 131(3):339-46. PubMed ID: 19228640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric, gene rearrangement, and karyotypic analyses of 110 cases of primary thyroid lymphoma: a single-institutional experience in Japan.
    Suzuki A; Hirokawa M; Higashiyama T; Fukata S; Takada N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2019 Dec; 66(12):1083-1091. PubMed ID: 31484843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of interleukin-7 and its receptor in thyroid lymphoma.
    Takakuwa T; Nomura S; Matsuzuka F; Inoue H; Aozasa K
    Lab Invest; 2000 Oct; 80(10):1483-90. PubMed ID: 11045564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytological differential diagnosis of autoimmune thyroiditis and low malignancy non-Hodgkin's lymphoma of the thyroid gland using genetic analytic procedures].
    Ruschenburg I; Schlott T; Kneba M; Reimer S; Droese M
    Verh Dtsch Ges Pathol; 1996; 80():302. PubMed ID: 9065032
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
    Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
    Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.